Targeting the Multi-Trillion Dollar Longevity Market
HONG KONG SAR -
Media OutReach Newswire - 27 August 2025 - Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company pioneering therapies for central nervous system (CNS) disorders and advancing science-based consumer health solutions, today...
Read more: Jupiter Neurosciences Launches Nugevia™ Website and Opens Pre-Orders for Groundbreaking Longevity...